Objective : To evaluate the relationship between the level of serum IL-6 and the prognosis of cervical cancer patients, because high level of IL-6 has been reported to be related with adverse prognosis in multiple myeloma, renal cancer, glioblastoma...
Objective : To evaluate the relationship between the level of serum IL-6 and the prognosis of cervical cancer patients, because high level of IL-6 has been reported to be related with adverse prognosis in multiple myeloma, renal cancer, glioblastoma, ovarian cancer and lymphoma. Methods : From June, 1997 to June 1998, total 58 patients including 29 patients with cervical cancer, 14 Carcinoma in situ, 15 control were enrolled in this study. We examined these patients of serum IL-6 by ELISA. Result : The mean serum IL-6 was 4.35±1.68pg/ml on control, 5.29±1.72pg/ml on carcinoma in situ and 5.57±4.10pg/ml in cervical cancer patients.Conclusion : Detectable serum IL-6 levels were more often in patients with cervical cancer and carcinoma in situ than in control group, but the difference was not statistically significant because of the small number of patients.